U.S. Markets closed

Startup Battlefield Competition - Elevian | Disrupt SF 2018

Elevian is a new company in partnership with Harvard, developing therapeutics that target regenerative capacity, the body’s ability to repair itself, which significantly declines with age. By targeting a fundamental mechanism of aging, Elevian’s medicines have the potential to treat or prevent many age-related diseases and extend healthy lifespan.